(Q33396658)
Statements
1 reference
A dose ranging phase I/II trial of the von Willebrand factor inhibiting aptamer ARC1779 in patients with congenital thrombotic thrombocytopenic purpura (English)
1 reference
Petra Jilma-Stohlawetz
1 reference
Bernd Jilma
1 reference
James C Gilbert
1 reference
Monika E Gorczyca
1 reference
Paul Knöbl
1 reference
11 August 2011
1 reference
1 reference
106
1 reference
539-547
1 reference
Identifiers
1 reference
1 reference